These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38161230)

  • 1. Antibody-Conjugated Magnetic Nanoparticle Therapy for Inhibiting T-Cell Mediated Inflammation.
    Hasan M; Choi JG; Akter H; Kang H; Ahn M; Lee SS
    Adv Sci (Weinh); 2024 Mar; 11(11):e2307148. PubMed ID: 38161230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow Characteristics of the Conjugate of Anti-CD3 Monoclonal Antibodies and Magnetic Nanoparticle in PBS and Blood Vessels.
    Lee SS; Kim EJ; Kang M; Kang H; Choi SH; Jeon D; Choi JG; Choi Y; Lee H; Hasan M
    Adv Exp Med Biol; 2022; 1395():357-362. PubMed ID: 36527662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-conjugation of anti-human CD3 monoclonal antibodies to magnetic nanoparticles by using cyanogen bromide: A potential for cell sorting and noninvasive diagnosis.
    Moradi N; Muhammadnejad S; Delavari H; Pournoori N; Oghabian MA; Ghafouri H
    Int J Biol Macromol; 2021 Dec; 192():72-81. PubMed ID: 34606792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.
    Hirsch R; Bluestone JA; DeNenno L; Gress RE
    Transplantation; 1990 Jun; 49(6):1117-23. PubMed ID: 2141740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise characterization method of antibody-conjugated magnetic nanoparticles for pathogen detection using stuffer-free multiplex ligation-dependent probe amplification.
    Chung B; Shin GW; Choi W; Joo J; Jeon S; Jung GY
    Electrophoresis; 2014 Dec; 35(23):3283-9. PubMed ID: 25070923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.
    Han WR; Murray-Segal LJ; Gershenzon A; Zhang JG; Hodder AN; Pietersz GA; Mottram PL
    Transpl Immunol; 1999 Dec; 7(4):207-13. PubMed ID: 10638833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8
    Sanz-Ortega L; Portilla Y; Pérez-Yagüe S; Barber DF
    J Nanobiotechnology; 2019 Aug; 17(1):87. PubMed ID: 31387604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R; Archibald J; Gress RE
    J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
    Herold KC; Bluestone JA; Montag AG; Parihar A; Wiegner A; Gress RE; Hirsch R
    Diabetes; 1992 Mar; 41(3):385-91. PubMed ID: 1532369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
    Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA
    J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targeting by lentiviral vectors combined with magnetic nanoparticles in mice.
    Borroni E; Miola M; Ferraris S; Ricci G; Žužek Rožman K; Kostevšek N; Catizone A; Rimondini L; Prat M; Verné E; Follenzi A
    Acta Biomater; 2017 Sep; 59():303-316. PubMed ID: 28688987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different coatings on magnetic nanoparticles dictate their degradation kinetics in vivo for 15 months after intravenous administration in mice.
    Portilla Y; Fernández-Afonso Y; Pérez-Yagüe S; Mulens-Arias V; Morales MP; Gutiérrez L; Barber DF
    J Nanobiotechnology; 2022 Dec; 20(1):543. PubMed ID: 36578018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal-invasive magnetic heating of tumors does not alter intra-tumoral nanoparticle accumulation, allowing for repeated therapy sessions: an in vivo study in mice.
    Kettering M; Richter H; Wiekhorst F; Bremer-Streck S; Trahms L; Kaiser WA; Hilger I
    Nanotechnology; 2011 Dec; 22(50):505102. PubMed ID: 22107782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice.
    Zhou YB; Ye RG; Li YJ; Xie CM; Wu YH
    Autoimmunity; 2008 Aug; 41(5):395-404. PubMed ID: 18568645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance.
    Riggio C; Calatayud MP; Hoskins C; Pinkernelle J; Sanz B; Torres TE; Ibarra MR; Wang L; Keilhoff G; Goya GF; Raffa V; Cuschieri A
    Int J Nanomedicine; 2012; 7():3155-66. PubMed ID: 22811603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.
    Wissing KM; Desalle F; Abramowicz D; Willems F; Leo O; Goldman M; Alegre ML
    Transplantation; 1999 Sep; 68(5):677-84. PubMed ID: 10507488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.